Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Foresee Pharmaceuticals reports positive Phase 1 trial results for Linvemastat Foresee Pharmaceuticals (TPEx: 6576) has reported successful preliminary results from its Phase 1 clinical trial of linvemastat (FP-020),… byPallavi MadhirajuOctober 21, 2024